The European agency in charge of drug monitoring changed its mandate and identity in 2024 — from EMCDDA to EUDA. Our role: align the website with the new brand from day one, without the "interim" solution showing.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) — the European Union agency in charge of drug monitoring — underwent a major transformation in 2024: a new, broader mandate, and a new identity, the European Drugs Agency (EUDA).
For a public institution, a name change is not a cosmetic detail: it is an official act, with an effective date, and a strong expectation of consistency between the legal mandate and everything visible to the public.
The website had to reflect the new identity at the exact moment of the announcement — not after. Yet a full redesign of an institutional site of this scale takes months.
Andromede was therefore tasked with a high-stakes, time-constrained project: adapt the existing site so it carried the new brand from day one, pending a deeper redesign later.
The pitfall to avoid: an "interim" solution that shows. A European agency cannot display a visibly improvised transition.
This is exactly the kind of project where Andromede's positioning makes full sense for institutional organisations — pragmatism, responsiveness, and a single point of contact who owns the case end to end.
No experimental stack. Solid, documented building blocks, with maintenance guaranteed for 10 years.
"A rare and valuable skill for institutional organisations: knowing how to deliver fast without ever sacrificing rigour. Andromede absorbed the pressure of the schedule."